Life Science Technology Inc.
285770·Unlisted · delisted·2 grantsAmendments merged
- Shares granted, cumulative
- 60,000shares
- Next lockup release
- —
Recipients by role
- Registered director1 person67%
- Other · unknown1 person33%
Sorted from the relation text written in the filings (2 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20211 grant · 20,000 shares
- Granted2021-03-29
- Exercise starts2023-03-29
- Exercise ends2025-03-28
- Shares granted
- 20,000shares
- Strike price
- 2,400KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting
[Amended] Report on grant of stock options
20201 grant · 40,000 shares
- Granted2020-03-27
- Exercise starts2022-03-27
- Exercise ends2024-03-26
- Shares granted
- 40,000shares
- Strike price
- 2,650KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting
[Amended] Report on grant of stock options
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.